ArticleOncology letters2019

PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy.

Hirofumi Kanaizumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.